MBA Croatia announces a new interesting lecture, May 21, 2019, at the Congress Center Forum Zagreb, starting at 18:00.
The lecture is held by Mr. Mislav Vučić, Executive Director of JGL.
The theme of the lecture is “Development and Growth of JGL”.
JGL is a company founded in 1991 as the first fully privately owned pharmaceutical company in Croatia.
The story of their success began with the separation from the Pharmacy “Jadran”, just after the break-up of Yugoslavia and the beginning of the production of generic drugs in the category of essential drugs. It was about small series medicines that were not interesting to the large pharmaceutical industry because they were not profitable.
Exiting from the local frameworks and expanding the business on the territory of Croatia, and then the region – Slovenia 1992, BiH in 1997 and Macedonia and Serbia in 2001 – made an additional step that created preconditions for further growth and development. The launch of operations on the markets of Russia (1998), followed by Ukraine (2004) and Kazakhstan (2006), from the current perspective has proved to be a key strategic decision for the company.
In manufacturing, the company strives to meet the diverse market demands of technological forms and therapeutic groups, so a wide range of JGL medicines allows doctors to choose the best cure for treating their patient.
Also, following the world trends and continually exploring the needs of customers, they developed a self-certification program that, with its innovation and quality, focuses on the prevention and maintenance of modern human health.
About the lecturer:
Mislav Vučić became the Chief Executive Officer of JGL in December 2017. In JGL comes from Teva Romania, where he has carried out the successful integration of Actavis as General Manager.
In his 20-year career in Pliva, Tivat and Sandoz, Mislav Vučić has gained experience in many areas of the pharmaceutical industry; prior to his current position in Teva, he was Senior Director of the Specialty Business unit (Innovation) for Central and Eastern Europe (CEE), Senior Director of Prices and Market Access for CEE, Senior Director of Portfolio Management for CEE, Senior Director of Commercial Operations and Business Development for South East Europe (SEE), Director of Business Development for Western Europe at Sandoz’s Central Office in Munich, Teva Europa’s Portfolio Manager in Amsterdam, and started his career at Pliva in 1998 in Strategic Marketing, where he later worked on acquisition projects.
Mislav Vučić holds an MBA from the Institute of Business Business School, one of the best business schools in Europe, and has graduated from the Faculty of Economics in Zagreb.
For members of the Association of MBA Croatia admission is free, while for the non – members, donation for this lecture is 80,00 kn and it can be donated through this link: